AFP - French pharmaceutical group Sanofi-Aventis said Friday it had withdrawn an application for regulatory approval for its anti-obesity drug Acomplia in the United States.
Reuters - Sanofi-Aventis SA is withdrawing its
application to sell obesity drug rimonabant -- its biggest new
drug hope -- in the United States, the French drugmaker said on
Friday.
Reuters - Sanofi-Aventis said on Friday it was
withdrawing its application to sell obesity drug rimonabant --
its biggest new drug hope -- in the United States.
HealthDay - TUESDAY, June 26 (HealthDay News) -- Using a plate and cereal bowl that
indicate proper portion sizes helped obese patients with diabetes lose
weight and decrease their use of glucose-controlling medications, says a
Canadian study.
Reuters - Elderly people who are obese appear
to have a lower risk of falling ill with tuberculosis compared
to those who are underweight or of average weight, according to
an extensive geriatric study in Hong Kong.
Reuters - Obese patients in Calgary, Alberta, are
the first in Canada to have a new ambulance on call specially
modified to move them in a dignified and safe way while
protecting paramedics from injury.
HealthDay - WEDNESDAY, June 20 (HealthDay News) -- In what doctors admit is a
paradox, new European research shows that obese patients have half the
risk of dying after a heart attack compared with normal-weight
patients.